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[17_TD$DIFF]Abstract
Background: Numerous epidemiological studies have suggested that metal
exposure may promote the atherosclerosis disorder in humans.
Objective: This study is carried out to assess the distribution, correlation and
multivariate apportionment of cadmium (Cd), cobalt (Co), chromium (Cr),
copper (Cu), iron (Fe), manganese (Mn), lead (Pb) and zinc (Zn) in the blood
of atherosclerosis patients in comparison with healthy donors.
Method: The quantification of metals is done by atomic absorption
spectrometry, after wet-acid digestion of the blood samples.
Results: Significantly higher concentrations of cadmium, chromium, copper,
iron and manganese are found in the blood of atherosclerosis patients. The
correlation study shows diverse relationships among the metals in blood of the
patients and controls. Multivariate cluster analysis based on the metal levels in
patients and controls reveals clearly separate grouping for the patients and
healthy donors. Moreover, principal component analysis shows divergent
grouping of the metals for the patients and healthy donors, which may be
associated with the altered metabolism of the metals in atherosclerosis patients.
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Conclusion: Overall, the distribution, correlation and multivariate apportionment
of selected metals in atherosclerosis patients and healthy donors are significantly
divergent. Hence, present findings suggest that the trace and redox metals
accumulated in the body may pose a high risk for atherosclerosis development.
Keywords: Atherosclerosis, Clinical biochemistry, Medical science, Atomic
spectroscopy
1. Introduction
Progressive urbanisation, industrialisation and poor food quality contributed to
the rising burden of cardiovascular disease (CVD) in the developing world [1].
This is mainly the result of increasing prevalence of atherosclerosis; a hallmark
of ischemia heart disease which occurs due to the accumulation of lipids/fibrous
elements in arteries [2,3]. Atherosclerosis development depends on the balance
between pro-inflammatory stimuli, anti-inflammatory and antioxidant defence
mechanisms [4, 5]. A critical event in early stages of atherosclerosis is the role
of low-density lipoprotein oxidation by some trace metals in atherogenesis and
the focal accumulation of lipid-laden foam cells derived from macrophages [6].
Major risk factors for atherosclerosis are hyperlipidemia, elemental imbalance,
hypertension, age, cigarette smoking, obesity, genetic factors, low income and
low levels of education in third world countries especially in Pakistan [1].
The significance of trace metals is clearly understood from the fact that slight
changes in their concentration in human body trigger some kind of
complications which later on develop into life threatening diseases [7]. It is
well established that trace metals play vital role as activators or inhibitors of
enzymatic reactions, by competing with other metals/proteins for binding sites,
by influencing the permeability of cell membranes, or through other mechanisms
[8]. Trace metals are recognized as essential mediators for the development and
progression of cardiovascular disease, although there is no concrete evidence for
the direct relationship between the metals and progression of the disease [9, 10].
Blood is one of the widely used specimens for biological metal research because
of its natural significance and ease of sampling [7, 11, 12]. It is the medium of
transport of trace metals and provides direct evidence about their concentrations
and therefore, considered as a good indicator of the current body burden of the
metals [13].
The present investigation is aimed at the measurement of Cd, Co, Cr, Cu, Fe,
Mn, Pb and Zn concentrations in blood samples of atherosclerosis patients and
healthy subjects. The objectives of this study are to evaluate the comparative
distribution, mutual correlations and multivariate apportionment of selected
metals in blood samples of the patients and healthy subjects. Information about
the variations in metal levels in atherosclerosis patients with respect to the
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healthy donors might help to scrutinize the possible role of these metals in the
initiation and development of the disease.
2. Materials and methods
2.1. Study population
A total of 90 atherosclerosis patients, aged between 30 and 62 years, were
included in this study, on volunteer basis. Blood samples were collected from
the patients admitted in Punjab Institute of Cardiology (PIC [6_TD$DIFF]), Lahore, Pakistan.
All the patients were newly diagnosed and were not taking any mineral
supplement for last three months. Before the sample collection, protocol of
the study was approved by the human ethical committee of the hospital
(App. No. QAUC/2012/PIC-A53). The diagnosis of CVD in patients had
previously been established by a specialist cardiologist, by performing and
analysis of the angiograms using routine procedure before blood was taken for
biochemical assays. The presence of 1 or more stenoses ≥50% in diameter of at
least in one major coronary artery was considered as the evidence of significant
CVD in the patient [14, 15]. The control subjects ([5_TD$DIFF]n = 90) were also selected
on volunteer basis from the same localities and matched with patients for
gender, age, environment, food habits and socioeconomic status (Table 1).
Before the sample collection, all subjects were briefed about the aim of the
study and they agreed to precipitate on volunteer basis. A signed consent was
Table 1. Characteristics of the Subjects.
Characteristics Atherosclerosis Patients
( [5_TD$DIFF]n = 90)
Healthy Donors
( [5_TD$DIFF]n = 90)
Age (yrs)
Range 30–62 33–61
Mean 45.5 46.4
Gender
Female 45 (50%) 45 (50%)
Male 45 (50%) 45 (50%)
Diet
Vegetarian 63 (70%) 63 (70%)
Non-vegetarian 27 (30%) 27 (30%)
Residence
Urban 63 (70%) 75 (83%)
Rural 27 (30%) 15 (17%)
Use of tobacco
No use 48 (53%) 48 (53%)
Use 42 (47%) 42 (47%)
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obtained from each of them. A pro-forma was filled to record the information
such as age, sex, ailment duration, food habits, smoking habits and occupation
at the time of sample collection from the subjects of both categories.
2.2. Sample collection and preparation
The blood samples were collected from antecubital vein with the help of
pre-cleansed syringe by venipuncture method. The blood samples were
immediately transferred to the evacuated polyethylene tubes. Every care was taken
to reduce the possibility of contamination during the sample collection. This
collection method was selected in present study because it dose not involve any
kind of chemical containing tubes. Samples were kept in refrigerator at
–15 °C until analyses were performed [16]. This method is free of any chemical
contamination during the sample collection hence it was suitable for accomplishing
the accurate results. Blood sample was transferred from storage tube to the
digestion flask and accurately weighed. It was followed by addition of 10 mL
HNO3 and left for 5 min; afterwards 10 mL HClO4 was added. The flasks were
then closed with their screw caps and kept for 15 min at room temperature. This
method previously was optimized by using different proportions of these acids, out
of which 1:1 (v/v) of HNO3 and HClO4 was the best choice. The sample contents
were then placed in a microwave oven at 500 watts for 5 min. The contents were
then cooled down to room temperature. This heating and cooling process was
repeated for couple of times more, so a total of 15 min were given for heating
inside the microwave oven. At this point the samples were completely digested.
A blank sample was also processed in the same manner along with each batch. The
blank contained all the reagents in the same sequence and having the same steps
except the sample was not present in it. The digested samples were transferred to
the volumetric flasks (25 mL) and final volume was appropriately adjusted. This
microwave digestion method has many advantages over other methods; it is
relatively easy/simple, it involves least chance of contamination, it is
environmental friendly and it is more accurate in the metal analysis [17].
2.3. Quantification of the metals
Quantitative analysis of Cd, Co, Cr, Cu, Fe, Mn, Pb and Zn was carried out on
flame atomic absorption spectrophotometer (Shamidzu AA-670, Japan), with
automatic background compensation and under optimum analytical conditions
as shown in Table 2, which also enlists the limit of detection and limit of
quantification of the metals. Three sub-samples of each sample were treated and
run separately onto the spectrophotometer to pool the mean concentrations.
Parallel routine check on the accuracy of quantified results was ensured through
the use of standard reference material (NIST SRM 1598a), which showed very
good recovery (Table 2). All reagents used were of ultrahigh purity
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(certified > 99.9%) procured from E-Merck, Germany. Working standard
solutions were prepared by serial dilution of 1000 mg L−1 stock standard
solutions, just before the analysis of the metals on the instrument.
2.4. Statistical analyses
Mean, geometric mean (GM), median, range, standard deviation (SD) and
skewness were computed along with correlation analysis and multivariate
statistics in terms of principal component analysis (PCA) and cluster analysis
(CA) were also carried out [17].
3. Results and discussion
3.1. Characteristics of the subjects
The demographic characteristics of the atherosclerosis patients and healthy
subjects/controls are given in Table 1. Gender characteristics of the subjects of
both categories were closely matched (50% each). Majority of them (70%) were
vegetarians. Seventy percent of the patient group and 83% of the control group
were from urban areas. About half of the patients and controls (53%) were
non-smokers.
3.2. Distribution of selected metals
Most metals exhibit broad ranges of concentrations in both donor-groups
(Table 3). Highest mean levels in blood samples of the patients are found for Fe
(420 μg g−1), followed by Zn (4.24 μg g−1), Pb (3.73 μg g−1), Co (1.41 μg g−1),
Table 2. Optimum analytical conditions for the metal analyses along with their limits of detection and
quantification and certified Vs measured (± SD) concentrationsa (μg L−1) of the metals in standard
reference material (NIST SRM 1598a).
Metal Wavelength
(nm)
Slit width
(nm)
Limit of Detection
(mg L−1)
Limit of Quantification
(mg L−1)
NIST SRM 1598a
Certified
Level
Measured
Level
Recovery
(%)
Cd 228.8 0.3 0.004 0.013 0.048 0.046 ± 0.005 96
Co 240.7 0.2 0.005 0.016 1.24 1.21 ± 0.09 98
Cr 357.9 0.5 0.006 0.018 0.33 0.31 ± 0.08 94
Cu 324.8 0.5 0.004 0.013 1580 1560 ± 88 99
Fe 248.3 0.2 0.006 0.018 1680 1651 ± 95 98
Mn 279.5 0.4 0.003 0.010 1.78 1.73 ± 0.36 97
Pb 217.0 0.3 0.010 0.029 – – –
Zn 213.9 0.5 0.002 0.006 880 892 ± 31 101
a Triplicate sub-samples.
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Mn (1.31 μg g−1), Cr (1.31 μg g−1), Cu (1.21 μg g−1) and Cd (0.70 μg g−1). On
the average basis, the decreasing trend of the metal levels in the blood of
atherosclerosis patients reveal following order: Fe > Zn > Pb > Co > Mn > Cr >
Cu > Cd. Some of the metals exhibit appreciable randomness in their distribution
pattern as manifested by dissimilar mean, geometric mean and median levels, as
well as relatively higher SD and skewness values. In case of healthy subjects,
higher average concentration is noted for Fe (350 μg g−1), followed by Pb
(4.94 μg g−1), Zn (4.84 μg g−1), Co (1.41 μg g−1) and Cu (1.01 μg g−1), while Cr,
Cd and Mn are measured at the lowest concentrations. Most of the metals exhibit
random distribution in blood of healthy donors as indicated by higher SD and
skewness values; the dispersion in the levels is comparatively lower than the
patients. The metals in the blood of healthy subjects show the following order in
their mean concentrations: Fe > Pb > Zn > Co > Cu > Cr > Cd > Mn (Table 3).
Relatively higher metal levels in the blood of both donor groups may be attributed
to their abode, food habits and tobacco use. Most of the subjects are residing in
urban areas where they are exposed to relatively higher pollutant levels which may
partially be attributed to diet/vegetables. Almost half (47%) of the participants are
using tobacco which is well known contributor for Cd.
Most of the metals show relatively large spread in the blood of atherosclerosis
patients except Fe which reveals narrow distribution. In case of controls, most
of the metals exhibit comparatively narrow distribution then the patients with
the exception of Zn, thus indicating more consistent concentrations and
relatively lower variations in the blood of controls. Moderately symmetric
distributions are observed for Cd and Zn in the blood of healthy subjects.
Table 3. Statistical distribution parameters for the metals concentrations (μg g−1) in blood of
atherosclerosis patients and healthy donors.
Atherosclerosis Patients Healthy Donors p-value
Range Mean GMa Median SDb Skew Range Mean GMa Median SDb Skew
Cd 0.02–1.91 0.70 0.54 0.71 0.52 0.71 0.08–1.11 0.50 0.42 0.52 0.33 0.44 <0.01
Co 0.22–3.40 1.41 1.04 1.31 0.91 0.64 0.12–3.02 1.41 1.23 1.42 0.72 0.43 NSc
Cr 0.14–4.21 1.31 0.91 1.11 1.04 1.21 0.04–2.24 1.01 0.71 0.91 0.64 0.52 <0.01
Cu 0.20–2.43 1.21 1.02 1.20 0.52 0.52 0.14–2.21 1.01 0.93 1.03 0.44 0.82 <0.05
Fe 230–700 420 403 390 122 0.73 140–690 350 330 340 116 0.74 <0.05
Mn 0.03–6.50 1.31 0.62 0.51 1.73 1.61 0.01–1.32 0.40 0.32 0.31 0.33 1.21 <0.001
Pb 0.13–13.8 3.73 1.61 1.11 4.11 1.14 0.34–15.1 4.94 2.91 2.73 4.41 0.92 NSc
Zn 0.81–8.51 4.24 3.74 3.73 2.02 0.44 0.72–12.3 4.84 4.23 4.32 2.41 0.94 NSc
aGM – geometric mean.
b SD –standard deviation.
c NS – non-significant.
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3.3. Comparison of average metal levels in the patients and
healthy subjects
Average metal levels in blood samples of the patients and healthy donors are
compared to find out the significant differences by applying t-test (Table 3). Mean
concentrations of Mn (p < 0.001), Cd (p < 0.01), Cr (p < 0.01), Fe (p < 0.05)
and Cu (p < 0.05) are found to be significantly higher in blood samples of
atherosclerosis patients than healthy donors. However, in case of controls the
average blood levels of Pb and Zn are observed to be slightly higher than the
patients but the differences are statistically insignificant. Average concentration of
Co is comparable in blood of the two donor groups. Significantly elevated levels
of Mn, Cd, Cr, Fe and Cu in the blood of atherosclerosis patients indicate
considerable association of these metals with the disease.
3.4. Correlation study
Significant positive correlations in blood of the patients are noted between
Pb–Fe (r = 0.51), Fe–Zn (r = 0.33) and Cr–Pb (r = 0.33) as shown in Table 4.
Some of the metals reveal inverse relationships manifested by significantly
negative correlations; Cd–Pb (r = -0.47) and Co–Pb (r = -0.31), which indicate
the depletion or enrichment of specific metals at the cost of others. The
correlation study shows mutual relationships among the trace and essential
metals; Pb and Cr with Fe and Zn which indicate their significant association
with the onset and/or progress of the disease. Apparently positive correlation of
the trace with essential metals evidences a build-up of the trace metals in the
blood of the patients. In case of healthy subjects, strong positive correlations are
noted between Fe–Zn (r = 0.64), Mn–Pb (r = 0.59), Zn–Cu (r = 0.53) and
Mn–Cd (r = 0.50). Some other significant correlations are also observed in
Table 4. Correlation coefficient (r)a matrix of the metals in blood of
atherosclerosis patients (below the diagonal) and healthy donors (above the
diagonal).
Cd Co Cr Cu Fe Mn Pb Zn
[8_TD$DIFF]Cd 1 0.24 0.01 0.13 0.02 0.50 0.37 -0.12
[9_TD$DIFF]Co 0.22 1 0.20 0.27 0.17 -0.06 -0.07 -0.02
[10_TD$DIFF]Cr -0.17 -0.07 1 0.29 0.27 0.14 0.37 0.14
[11_TD$DIFF]Cu 0.19 -0.08 -0.17 1 0.45 -0.15 -0.14 0.53
[12_TD$DIFF] e -0.14 -0.22 0.07 0.23 1 0.14 0.23 0.64
[13_TD$DIFF]Mn 0.13 0.12 -0.09 0.18 0.20 1 0.59 -0.22
[14_TD$DIFF]Pb -0.47 -0.31 0.33 0.19 0.51 -0.12 1 -0.11
[15_TD$DIFF]Zn 0.23 0.16 -0.07 0.17 0.33 0.02 -0.10 1
a Bold r-values are significant at p [16_TD$DIFF]≤ 0.01.
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blood of the controls; Pb–Cr and Pb–Cd. Consequently, most of the essential
metals reveal strong mutual correlations in the blood of the controls. The
demographic characteristics of the patients and controls mostly remained
comparable (Table 1); hence the mutual relationships among the metals are not
affected by these factors. Overall, correlation pattern of the metals in blood of
controls remain noticeably different compared to the atherosclerosis patients,
which may be attributed to the disproportions of the nutrients and trace metals
in the patients.
3.5. Multivariate analyses
Multivariate analysis of the data using principal component and cluster analysis
is another important aspect of the present study [18]. Cluster analysis of the
subjects based on the metals levels in patients and controls reveal clearly
separate grouping for the patients and healthy donors (Fig. 1) thus indicating
diverse apportionment which may be applied for clinical and prognostic studies.
Therefore, multivariate apportionment of the metals in the patients and controls
are further applied to explore the diagnostic significance. PCA of metals in
blood of the patients and healthy donors, extracted by using varimax normalized
rotation on the data-set is shown in Fig. 2, as graphical form between PC1
(eigen value = 4.4) and PC 2 (eigen value = 2.6) which contribute 27.4 and
16.1% of the total variance, respectively. Interestingly, the metals constitute two
distinctly different groups; one for the patients and other (except Fe and Pb) for
healthy donors. Therefore, PCA shows diverse associations among the metals in
atherosclerosis patients and healthy subjects which may be attributed to the
altered metabolism of the metals in the patients. Among the metals in healthy
donors, Fe and Pb show different behaviour which may be due to the
[(Fig._1)TD$FIG]
Fig. 1. Cluster analyses of the subjects (atherosclerosis patients (P) and healthy donors (H)) based
on metal levels in their blood.
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anthropogenic impact of these metals as most of the healthy subjects (83%) are
residing in urban areas where these metals are mainly associated with the
anthropogenic activities. Additionally, significant numbers of controls are using
tobacco on continuous basis (47%) and most of them were vegetarians (70%);
the elevated metal levels may be attributed to their intake through food chain.
Thus, PCA point out imbalance of Fe and Pb in healthy donors. Overall, PCA
evidence noteworthy disproportions in the multivariate apportionment of the
metals in blood of atherosclerosis patients compared with healthy subjects.
Several epidemiological studies have shown that some metals may be associated
with the progression and development of CVD [6, 11, 19, 21]. Generally, high
blood levels of Cd are associated with the initiation of atherosclerosis, which
may be due to the hypertensive effects of Cd and its ability to cause endothelial
cell damage. The role of Cd in development of atherosclerosis starts after its
inhalation or ingestion and followed by its transfer as a free ion or protein-
bound (attached to albumin or metallothioneins) via bloodstream to the different
organs. Usually, Cd is taken up by cells of the target organs (e.g., aortic vessel
wall) where it accelerates the formation of plaque in lumen of the artery. That's
why Cd is reported to be an independent risk factor for early atherosclerotic
vessel wall thickening in newly diagnosed patients [11, 19]. In present study Cd
is reported noticeably higher in blood of patients than healthy donors (Table 3).
Despite the metabolic essentiality of Cr, its deficiency may cause atherosclerosis
because Cr is an important component of the lipid and protein metabolism in
human body. It has been reported that cholesterol especially low-density
lipoprotein (LDL) decrease significantly when subjects were ingesting chromium
picolinate. Moreover, animal studies especially on rabbit support the role of
chromium picolinate on lipoprotein metabolism [20]. Many past studies examine
[(Fig._2)TD$FIG]
Fig. 2. Principal component analysis of the metals in blood of atherosclerosis patients ([3_TD$DIFF]p) and
healthy donors ( [4_TD$DIFF]h).
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the oxidation of LDL via reactive oxygen species (ROS), which later on induce
the atherosclerosis [6].
Copper is also an essential metal that plays a critical role in haemoglobin
synthesis, immune functions and as a cofactor for Cu/Zn superoxide dismutase
and ceruloplasmin in a define range. High blood Cu level is thought to be an
independent risk factor for CVD especially myocardial infarction and
atherosclerosis [21]. Chronic inflammation, as indicated by increased levels of
serum C-reactive protein, is associated with elevated levels of Cu. Due to the
redox active nature of Cu, it catalyzes the production of highly reactive oxygen
species which have the potential to cause oxidative damage to proteins, DNA,
lipids and other molecules. As a result, Cu overload induces the tissue injuries,
which may lead to diseases or affect the progression of diseases [22, 23].
Present study show the higher blood Cu level in patients (Table 3), which may
further strengthen the above statements about cardio-toxic effect of Cu.
Though Mn is an essential metal for health in trace amount but at higher level it
shows toxic effects. It is very important component of enzymatic antioxidants
which is the defence part of our body. In some past studies, Mn contents of the
heart and aorta of atherosclerotic subjects were lower and plasma levels were
higher than the healthy controls. The rise was so rapid and specific that it may be
used as a diagnostic indicator of myocardial infarction [22]. In the present study,
Mn concentration was higher in the blood of atherosclerosis patients compared to
the controls (Table 3) which supported the above mentioned hypothesis.
Iron is an important part of haemoglobin and various enzymes in human body
but higher concentration of free iron is involved in oxidative stress. Its overload
leads to free radical damage by the Fenton reaction. This reaction occurs when
Fe2+ reacts with hydrogen peroxide to generate hydroxyl radicals/ions and
highly reactive intermediates, causing oxidative stress in the cell. These reactive
oxygen species are involved in the peroxidation of lipoproteins and in
consequence produce the oxidized LDL, which along with other factors lead
towards the development of atherosclerosis [24, 25]. In the present study, Fe
levels tend to be higher in atherosclerosis patients (Table 3).
Lead (Pb) is one of the toxic metals that directly interrupts the activity of
enzymes, competitively inhibits absorption of important trace minerals and
deactivates antioxidant pools [26]. The cardiovascular effects of Pb are
associated with increased blood pressure and hypertension. Several animal
studies supported the fact that Pb promotes the ROS generation which later on
induce the hypertension [27]. Studies in general populations have identified a
positive association of Pb exposure with CVD (e.g., coronary artery disease,
stroke, and peripheral arterial disease) [22, 28]. In the present study, Fe and Pb
show a significant positive correlation in case of the patients (Table 4). This
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positive correlation indicates that these metals side by side play a crucial role in
the development of oxidative stress.
In the present study, Cu and Zn are antagonistic to each other; Cu concentration
is higher in blood samples of the patients, while, Zn concentration is lower.
Epidemiological relevance between Zn status and CVD incidence is rare;
however protective effects of Zn on the risk of CVD are found in some
published data [29]. In one of the animal study, developing of atherosclerotic
plaques in cholesterol-fed rabbits are enriched with Fe but depleted with Zn,
which may have an antiatherogenic effect by decreasing Fe levels in the lesion,
possibly leading to inhibition of iron-catalyzed free radical reactions which
express the antioxidant and anti-inflammatory properties of Zn [30].
4. Conclusions
In conclusion, the present study evidences significant disparities in distribution
of the metals in blood of the patients in comparison with the controls. Average
concentrations of Cu, Fe, Cr, Cd and Mn are significantly higher in the blood of
atherosclerosis patients which represents the change in body metal homeostasis.
These metal imbalances may be a triggering factor for the development of CVD.
The correlation study exhibits appreciably diverse associations of the metals in
blood samples of the two groups. Moreover, positive correlation of the trace
with essential metals evidences a build-up of the trace metals in the blood of the
patients. Multivariate CA of the subjects based on the metals levels in patients
and controls reveal clearly separate grouping for the patients and healthy donors,
while multivariate PCA reveal significantly dissimilar grouping of the metals in
the patients and controls; thus highlighting the significant role of trace metals in
atherosclerosis in human. The results of this study provided guideline to the
other researchers investigating the role of trace and toxic metals in the disease.
However, more studies including other essential and toxic metals in different
biological samples should be conducted to explore the potential relationship
between elemental imbalance and the development of CVD. In addition, future
studies should take account of other CVD risk factors, such as, hyperlipidemia,
hypertension and obesity along with metal imbalances in order to understand the
clearer picture of atherosclerosis mechanism.
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